Company Overview and News

 
Orezone Gold Closes C$44.92 Million Private Placement

2018-04-10 globenewswire
OTTAWA, April 10, 2018 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX-V:ORE) (“Orezone” or the “Company”) is pleased to announce that it has closed its non-brokered private placement (the “Offering”) previously-announced on March 26, 2018. The Company has sold 56,150,000 common shares of the Company (“Common Shares”) at a price of C$0.80 per share for gross proceeds of C$44,920,000. The Common Shares issued pursuant to the Offering will be subject to a four month hold period expiring on August 10, 2018.
Upvote Downvote

 
BRIEF-Resource Capital Fund VII announces acquisition Of 19.99 pct of Orezone Gold Corp shares

2018-04-10 reuters
* RESOURCE CAPITAL FUND VII L.P. ANNOUNCES ACQUISITION OF 19.99% OF SHARES OF OREZONE GOLD CORPORATION
Upvote Downvote

 
ORZCF / Orezone Gold Corp. / VAN ECK ASSOCIATES CORP - 3G/A (Passive Investment)

2018-02-12 sec.gov
schedule13g.htm     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)*       Orezone Gold, Inc. (Name of Issuer)  COMMON SHARES    (Title of Class of Securities) 68616T109     (CUSIP Number) December 31, 2017 - Year End Filing     (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   [X] Rule 13d-1(b) [ 
Upvote Downvote

 
ORZCF / Orezone Gold Corp. / VAN ECK ASSOCIATES CORP - 3G/A (Passive Investment)

2018-02-12 sec.gov
schedule13g.htm     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)*       Orezone Gold, Inc. (Name of Issuer)  COMMON SHARES    (Title of Class of Securities) 68616T109     (CUSIP Number) December 31, 2017 - Year End Filing     (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   [X] Rule 13d-1(b) [ 
Upvote Downvote

12
Top 20 Gold Mining Stocks For 2018

2018-01-02 seekingalpha
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
Upvote Downvote

2
Resource Sector Digest: Coeur Spends Big On Silvertip

2017-09-20 seekingalpha
In case you missed out on previous editions of this newsletter, simply click here, here or here to catch up. Chances are that if you like this newsletter, you will like Itinerant Musings even better. Please consider signing up for a free two-week trial now; the offer closes at the end of this week.
Upvote Downvote

 
Sarama Resources Intersects 10.4M @ 3.96g/t Au in Deep Drilling at the South Hounde Project in Burkina Faso

2017-08-16 marketwired
VANCOUVER, BC--(Marketwired - August 16, 2017) - Sarama Resources Ltd. ("Sarama" or the "Company") (TSX VENTURE: SWA) announces that gold mineralisation at the MC Deposit has been extended at depth and along strike in a deep diamond drilling program at the South Houndé Project (the "Project") in south-western Burkina Faso.
Upvote Downvote

 
Sarama Resources Announces Completion of C$1,850,000 Private Placement

2017-08-03 marketwired
Sarama Resources Limited ("Sarama" or the "Company")(TSX VENTURE: SWA) announces that it has completed its previously announced private placement (the "Private Placement").
Upvote Downvote

 
Gold Bull Portfolio: Recent News And Month In Review

2017-08-02 seekingalpha
Kirkland Lake Gold reports impressive results; insider buying activity picks up at 5 gold companies; Sandstorm-Mariana deal analyzed.
Upvote Downvote

 
Sarama Resources Announces Private Placement to Fund Exploration Programs in Burkina Faso

2017-07-20 marketwired
Sarama Resources Ltd. ("Sarama" or the "Company") (TSX VENTURE: SWA) announces that it is conducting a private placement (the "Private Placement") to raise gross proceeds of up to C$2,500,000. The Private Placement will involve the issuance of up to 13,888,889 common shares of Sarama (the "Shares") at a price of C$0.18 per Share.
Upvote Downvote

 
Sarama Resources Announces Government Approval to Transfer Bondi Gold Deposit

2017-07-19 marketwired
VANCOUVER, BC--(Marketwired - July 19, 2017) - Sarama Resources Ltd. ("Sarama" or the "Company") (TSX VENTURE: SWA) is pleased to advise that the Ministry of Mines and Quarries in Burkina Faso has issued, and Sarama has paid, the invoice for the transfer of the Djarkadougou Exploration Permit ("Djarkadougou"), which hosts the Bondi Gold Deposit ("Bondi Deposit"). This was acquired from Orezone Gold Corporation ("Orezone"), pursuant to the sale agreement between Sarama and Orezone (the "Agreement") (refer Sarama news release May 24, 2016).
Upvote Downvote

 
Sarama Resources Identifies Gold-In-Soil Anomalism Over 10km-Long Trend at Its 100%-Owned Botoro Property in Burkina Faso

2017-07-05 marketwired
VANCOUVER, BC--(Marketwired - July 05, 2017) - Sarama Resources Ltd. ("Sarama" or the "Company") (TSX VENTURE: SWA) is pleased to report that the first phase of exploration on the Company's recently-acquired1 Botoro Property ("Botoro" or the "Property") in south-west Burkina Faso has identified several gold-bearing quartz vein systems associated with regional shear zones and a preliminary soil geochemistry survey has returned gold-in-soil anomalism associated with structural features over a distance of approximately 10km.
Upvote Downvote

 
Sarama Resources Intersects High-Grade Gold Mineralisation at the South Hounde Project in Burkina Faso

2017-06-19 marketwired
VANCOUVER, BC --(Marketwired - June 19, 2017) - Sarama Resources Ltd. ("Sarama" or the "Company") (TSX VENTURE: SWA) is pleased to announce that high-grade gold mineralisation has been intersected in an ongoing extensional diamond drilling program at the South Houndé Project (the "Project") in south-western Burkina Faso.
Upvote Downvote

 
Which Gold Junior Will Get Taken Over Next?

2017-06-13 seekingalpha
El Dorado announced last month it would buyout Integra Gold in a C$590 million deal; I previously listed Integra as a top takeover target.
Upvote Downvote

 
Sarama Resources Increases Exploration Interests in the Hounde Belt, Burkina Faso

2017-05-16 marketwired
VANCOUVER, BC--(Marketwired - May 16, 2017) - Sarama Resources Ltd. ("Sarama" or the "Company") (TSX VENTURE: SWA) is pleased to advise that it has agreed to acquire a 100% interest in the Botoro exploration property ("Botoro" or the "Property") in south-west Burkina Faso. Botoro complements Sarama's mineral property interests in the highly prospective southern Houndé Belt and increases the size of its 100%-owned4 ThreeBee Project to approximately 660km².
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 68616T109